Academic Journal
138O CNS metastases in HER2-positive metastatic breast cancer treated with trastuzumab deruxtecan: DESTINY-Breast01 subgroup analyses
| العنوان: | 138O CNS metastases in HER2-positive metastatic breast cancer treated with trastuzumab deruxtecan: DESTINY-Breast01 subgroup analyses |
|---|---|
| المؤلفون: | Jerusalem, G., Park, Y.H., Yamashita, T., Hurvitz, S.A., Chen, S., Cathcart, J., Lee, C., Perrin, C. |
| المساهمون: | Roche, Novartis, AstraZeneca, Merck KGaA |
| المصدر: | Annals of Oncology ; volume 31, page S63-S64 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2020.03.239 |
| الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2020.03.239 https://api.elsevier.com/content/article/PII:S0923753420363183?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753420363183?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.AB66202A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.03.239 |
|---|